| LINC01193 |
|
long intergenic non-protein coding RNA 1193
|
|
|
0.565 |
0.692 |
| HLA-DRB4 |
P13762
|
major histocompatibility complex, class II, DR beta 4
|
Immune response
|
|
0.565 |
0.846 |
| HLA-DRB3 |
P79483
|
major histocompatibility complex, class II, DR beta 3
|
Immune response
|
|
0.570 |
0.885 |
| CECR |
|
cat eye syndrome chromosome region
|
|
|
0.599 |
0.731 |
| TRAP |
|
triiodothyronine receptor auxiliary protein
|
|
|
0.579 |
0.731 |
| MIR148B |
|
microRNA 148b
|
|
|
0.592 |
0.692 |
| RNR2 |
Q8IVG9
|
l-rRNA
|
|
|
0.603 |
0.692 |
| DBA2 |
|
Diamond-Blackfan anemia 2
|
|
|
0.599 |
0.731 |
| MIR196A2 |
|
microRNA 196a-2
|
|
|
0.599 |
0.577 |
| SPRR2A |
P35326
|
small proline rich protein 2A
|
|
|
0.612 |
0.731 |
| MIR337 |
|
microRNA 337
|
|
|
0.610 |
0.692 |
| IGHM |
P01871
|
immunoglobulin heavy constant mu
|
|
|
0.644 |
0.654 |
| IRGM |
A1A4Y4
|
immunity related GTPase M
|
|
|
0.617 |
0.538 |
| CPP |
|
ceruloplasmin pseudogene
|
|
|
0.631 |
0.731 |
| RAB4B-EGLN2 |
|
RAB4B-EGLN2 readthrough (NMD candidate)
|
|
|
0.641 |
0.654 |
| DNAJB1P1 |
|
DnaJ heat shock protein family (Hsp40) member B1 pseudogene 1
|
|
|
0.650 |
0.654 |
| TRA |
P0DSE1
|
T cell receptor alpha locus
|
|
|
0.628 |
0.577 |
| TRB |
P0DSE2
|
T cell receptor beta locus
|
|
|
0.636 |
0.538 |
| GCY |
|
growth control, Y chromosome influenced
|
|
|
0.631 |
0.615 |
| MUC3B |
Q9H195
|
mucin 3B, cell surface associated
|
|
|
0.666 |
0.462 |
| H3P44 |
|
H3 histone pseudogene 44
|
|
|
0.636 |
0.462 |
| GTS |
|
Gilles de la Tourette syndrome
|
|
|
0.682 |
0.615 |
| TRBV16 |
A0A087WV62
|
T cell receptor beta variable 16 (gene/pseudogene)
|
|
|
0.695 |
0.500 |
| TRBV7-9 |
P04435
|
T cell receptor beta variable 7-9
|
|
|
0.695 |
0.500 |
| TRBC1 |
P01850
|
T cell receptor beta constant 1
|
|
|
0.695 |
0.500 |